(A) Cross-trial comparison of response rate (ORR %) and median DOR in months for various agents studied in relapsed ES-SCLC (second line and beyond. Note: cross-trial comparison should be made with ...

Dr. Debu Tripathy, editor-in-chief of CURE magazine, discusses the advancements made in small cell lung cancer. Although advancements in treatments for small cell lung cancer (SCLC) are scarce for ...

Patients with limited-stage small cell lung cancer saw improvements in progression-free survival and overall survival with Imfinzi versus placebo. Patients with limited-stage (cancer that is only on ...

Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of lung cancer. One of the biggest challenges doctors face is the cancer's resistance to platinum-based chemotherapy ...

Bristol Myers Squibb’s (BMS) lung cancer monoclonal antibody BMS-986012 has nearly doubled overall survival (OS) in patients with extensive-stage small cell lung cancer (ES-SCLC) and brain ...

Opens in a new tab or window Treatment with the antibody drug-conjugate ifinatamab deruxtecan (I-DXd) showed promising activity in pretreated patients with extensive-stage small cell lung cancer ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of lung cancer cases. The treatment plan and goal of treatment depend on the stage of your ...

After studying Gandhi’s principles of civil disobedience in India, he joined the 1960s civil rights movement and became an architect of it as a nonviolent struggle. By Robert D. McFadden Before ...

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab Clinical ...

The Southern Christian Leadership Conference, the civil rights organization, is seeking to remove the president of its Los Angeles chapter in response to his support of same-sex marriage.